Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cnbx Pharmaceuticals Inc (CNBX)

Cnbx Pharmaceuticals Inc (CNBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.37
Trade CNBX with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0106 +50.00%
on 03/01/24
0.0179 -11.17%
on 03/04/24
+0.0030 (+23.26%)
since 02/28/24
3-Month
0.0085 +87.06%
on 01/31/24
0.0184 -13.59%
on 01/08/24
+0.0019 (+13.57%)
since 12/28/23
52-Week
0.0085 +87.06%
on 01/31/24
0.0980 -83.78%
on 04/03/23
-0.0061 (-27.73%)
since 03/28/23

Most Recent Stories

More News
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0159 (+13.57%)
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

/PRNewswire/ - CNBX Pharmaceuticals Inc. (OTC-QB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0159 (+13.57%)
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the...

CNBX : 0.0159 (+13.57%)
CNBX Pharmaceuticals Announces New Patent Granted in Australia

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0159 (+13.57%)
Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0159 (+13.57%)
EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0159 (+13.57%)
CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0159 (+13.57%)
CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0159 (+13.57%)
Seedo Corp. Appoints New Board of Directors

Yoqneam, Israel, July 01, 2020 (GLOBE NEWSWIRE) -- Seedo Corp. (OTC: SEDO) (“Seedo”) announced its shareholders have elected a new Board of Directors. The new Board brings decades of executive corporate,...

SEDO : 0.1310 (-12.90%)
BGEO.LN : 5,050.000 (-0.20%)
CNBX : 0.0159 (+13.57%)
XAIR : 1.7400 (unch)
APOP : 13.17 (+0.38%)
XTLB : 2.81 (+4.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.0208
2nd Resistance Point 0.0184
1st Resistance Point 0.0171
Last Price 0.0159
1st Support Level 0.0134
2nd Support Level 0.0110
3rd Support Level 0.0097

See More

52-Week High 0.0980
Fibonacci 61.8% 0.0638
Fibonacci 50% 0.0532
Fibonacci 38.2% 0.0427
Last Price 0.0159
52-Week Low 0.0085

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar